A Phase Ib Open-label, Multicenter Cross-over Study to Investigate the Effect of Food on the Rate and Extent of Oral LBH589 [panobinostat] Absorption in Patients With Advanced Solid Tumors.

Trial Profile

A Phase Ib Open-label, Multicenter Cross-over Study to Investigate the Effect of Food on the Rate and Extent of Oral LBH589 [panobinostat] Absorption in Patients With Advanced Solid Tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Nov 2012

At a glance

  • Drugs Panobinostat (Primary)
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 10 Jan 2012 Actual end date (1 Feb 2011) added as reported by ClinicalTrials.gov.
    • 17 Jun 2009 Status changed from recruiting to completed.
    • 02 Jun 2009 Results presented at the 45th Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top